The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDarktrace Regulatory News (DARK)

Share Price Information for Darktrace (DARK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 600.00
Bid: 599.80
Ask: 600.20
Change: 3.60 (0.60%)
Spread: 0.40 (0.067%)
Open: 598.60
High: 601.00
Low: 598.60
Prev. Close: 596.40
DARK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Conclusion of Ernst & Young LLP Review

18 Jul 2023 07:00

RNS Number : 2932G
Darktrace PLC
18 July 2023
 

Darktrace plc

18 July 2023

 

 

Conclusion of Ernst & Young LLP Review

 

Darktrace plc ("Darktrace") (DARK.L), a global leader in cyber security AI, announces that Ernst & Young LLP ("EY") has concluded its independent third-party review.

 

EY has delivered its written report and presented its findings to Darktrace's Audit and Risk Committee ("ARC"), all other Board members and Darktrace's independent auditors, Grant Thornton (UK) LLP ("Grant Thornton"). Further, copies of EY's report are being provided voluntarily to the Financial Conduct Authority and the Financial Reporting Council ("FRC") to ensure they also have full visibility of EY's review.

 

Neither Management, nor the Board consider EY's report to have any impact on Darktrace's previously filed public company financial statements nor to change their belief that those financial statements fairly represent Darktrace's financial position and results. In addition, Grant Thornton's audit opinions for prior years remain unchanged and the audit for FY23 is in progress.

 

Furthermore, since Darktrace's February statements, the Audit Quality Review ("AQR") team of the FRC, in accordance with its usual cycle of UK audit inspections, has undertaken an inspection of Grant Thornton's audit of Darktrace for the year ended 30 June 2022. There were no key findings arising from this inspection.

 

Darktrace gave EY unrestricted access to all information, employees, partners and customers necessary to allow it to conduct a thorough review of the policies, processes and controls related to the areas of scope referenced in its 20 February statement. The areas covered included Darktrace's treatment of partner channel contracts and marketing spend, contract opt-outs and appliance deployments, as well as the process for calculation of non-current deferred revenue. Darktrace also expanded EY's work to include a review of the process for calculating Annual Recurring Revenue and the status of certain third-party relationships.

 

In its review, EY reported a number of areas already known to Darktrace where systems, processes or controls could be improved. For example, as part of its work around channel processes and controls, EY reviewed a risk weighted sample of new channel contracts which identified a small number of errors and inconsistencies. Neither Management nor the Board consider these to be material to the financial statements and controls enhancements in this area are already underway.

 

Cathy Graham, Darktrace's CFO said, "We have a culture of continuous improvement at Darktrace. As you would expect and as we said in our FY22 Annual Report, we have an ongoing program to advance our systems, processes and controls. We have developments already underway, on our roadmap or under consideration across relevant areas of the business, including those covered in EY's review. EY provided some valuable recommendations for how we could implement these planned improvements as we move through this journey."

 

Gordon Hurst Chair of the Board, added, "We are pleased that EY has concluded its review and with the cooperation and transparency EY received from Darktrace employees at all levels. This has further reinforced the Board's confidence that Management has set a tone and culture consistent with good governance. Separately, the AQR team's review of Grant Thornton's audit for 30 June 2022, which identified no key findings, reinforces the confidence we have always had in the robustness of the audit process and the resulting independently audited public company financial statements. We trust that all stakeholders are reassured by these outcomes." 

 

Contact:

 

Luk Janssens - Head of Investor Relations, Darktrace

+44 7811 027918

luk.janssens@darktrace.com

 

Powerscourt (Public Relations adviser to Darktrace)

Peter Ogden/Victoria Palmer-Moore/Elly Williamson

+44 (0) 20 7250 1446

darktrace@powerscourt-group.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUBOKROUUBAAR
Date   Source Headline
8th May 202411:06 amRNSForm 8.5 (EPT/NON-RI) Darktrace Plc
8th May 202411:02 amRNSForm 8.5 (EPT/RI) -Darktrace PLC
8th May 202410:31 amRNSForm 8.5 (EPT/NON-RI) Darktrace Plc - Replacement
8th May 20249:56 amRNSForm 8.3 - Darktrace PLC
8th May 20249:56 amRNSForm 8.3 - Darktrace PLC
8th May 20249:55 amRNSForm 8.3 - Darktrace PLC
8th May 20249:16 amRNSForm 8.3 - Darktrace plc
8th May 20247:00 amRNSRule 2.9 Announcement
7th May 20243:20 pmRNSForm 8.3 - Darktrace plc
7th May 20243:00 pmRNSForm 8.3 - Darktrace PLC
7th May 202411:26 amRNSForm 8.5 (EPT/NON-RI) Darktrace Plc
7th May 202411:23 amRNSForm 8.5 (EPT/RI) - Darktrace
7th May 202410:02 amRNSForm 8.3 - Darktrace plc
7th May 20249:52 amRNSForm 8.3 - Darktrace plc
7th May 20249:47 amRNSForm 8.5 (EPT/NON-RI)
7th May 20247:00 amRNSForm 8.3 - Darktrace plc
6th May 20242:38 pmEQSForm 8.3 - The Vanguard Group, Inc.: Darktrace plc
6th May 20241:40 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Darktrace Plc
3rd May 20246:37 pmRNSForm 8.3 - Sale of DarkTrace shares
3rd May 20244:18 pmRNSForm 8.3 - Darktrace plc
3rd May 20243:20 pmRNSForm 8.3 - Darktrace plc
3rd May 20243:00 pmRNSForm 8.3 - Darktrace Plc
3rd May 20242:43 pmRNSForm 8.3 - Darktrace plc
3rd May 20242:41 pmRNSForm 8.3 - DARKTRACE PLC
3rd May 202411:49 amRNSForm 8.5 (EPT/RI) - Darktrace
3rd May 202411:34 amRNSForm 8.5 (EPT/NON-RI) - Darktrace plc
3rd May 202411:06 amRNSHolding(s) in Company
3rd May 20249:59 amRNSForm 8.5 (EPT/NON-RI) - Darktrace PLC
3rd May 20249:56 amRNSForm 8.3 - Darktrace plc
2nd May 20243:20 pmRNSForm 8.3 - Darktrace plc
2nd May 20243:00 pmRNSForm 8.3 - Darktrace PLC
2nd May 20242:46 pmRNSForm 8.3 - Darktrace plc
2nd May 20242:43 pmRNSForm 8.3 - Darktrace PLC
2nd May 202412:07 pmRNSForm 8.5 (EPT/RI) - Darktrace
2nd May 202411:46 amRNSForm 8.5 (EPT/NON-RI) Darktrace Plc
2nd May 202411:02 amGNWForm 8.3 - AXA INVESTMENT MANAGERS: Darktrace plc.
2nd May 202410:55 amRNSForm 8.5 (EPT/NON-RI)
2nd May 20247:00 amRNSForm 8.3 - Darktrace plc
1st May 20245:04 pmRNSHolding(s) in Company
1st May 20243:20 pmRNSForm 8.3 - Darktrace plc
1st May 20243:11 pmRNSForm 8.3 - Darktrace plc
1st May 20243:00 pmRNSForm 8.3 - Darktrace PLC
1st May 20242:56 pmRNSForm 8.3 - Darktrace plc
1st May 20242:50 pmEQSForm 8.3 - The Vanguard Group, Inc.: Darktrace plc
1st May 20242:21 pmRNSForm 8.3 - Darktrace plc
1st May 202412:00 pmRNSForm 8.5 (EPT/NON-RI) Darktrace Plc
1st May 202411:37 amGNWForm 8.3 - AXA INVESTMENT MANAGERS: Darktrace plc
1st May 202411:05 amRNSForm 8.5 (EPT/RI) - Darktrace
1st May 20249:25 amRNSForm 8.5 (EPT/NON-RI) - Darktrace PLC
1st May 20247:00 amRNSForm 8.3 - Sale of DarkTrace shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.